WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹306 Cr | ₹276 Cr | ₹260 Cr | ₹232 Cr | ₹288 Cr |
What is the latest Net Current Assets ratio of WINDLAS BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹306 Cr |
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹232 Cr |
| Mar2022 | ₹288 Cr |
How is Net Current Assets of WINDLAS BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹306 Cr | 10.85 | |
| Mar2025 | ₹276 Cr | 6.34 | |
| Mar2024 | ₹260 Cr | 11.73 | |
| Mar2023 | ₹232 Cr | -19.25 | |
| Mar2022 | ₹288 Cr | - | |
Compare Net Current Assets of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,252.6 Cr | 11.3% | 26.9% | 1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 11.3% |
26.9% |
1.4% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses